avatar
j*a
1
各位同鞋给看看吧,多谢。条件如下:
1. Ph.D. in chemical engineering.
2. Working in a international pharmaceutical company as a scientist.
3. 6 published papers (with 5 1st author) mostly with pharmaceutical
sciences journal, 1 more paper will be accepted before filing EB1B (1st
author)
4. No award, no media report
5. Two patent applications, both as the last inventor (does it matter?)
6. Prepare to get 6 reference letters, (got three already, two independent
from europe and one from US)
7. Review 57 times for 9 journals in cluding top journals in pharmaceutical
sciencs and chemical engineering
8. Indepedent citations ~30 (it is weird, no new citations starting from
this year) from 9 countries.
avatar
b*n
3
strong
go for it

pharmaceutical

【在 j****a 的大作中提到】
: 各位同鞋给看看吧,多谢。条件如下:
: 1. Ph.D. in chemical engineering.
: 2. Working in a international pharmaceutical company as a scientist.
: 3. 6 published papers (with 5 1st author) mostly with pharmaceutical
: sciences journal, 1 more paper will be accepted before filing EB1B (1st
: author)
: 4. No award, no media report
: 5. Two patent applications, both as the last inventor (does it matter?)
: 6. Prepare to get 6 reference letters, (got three already, two independent
: from europe and one from US)

avatar
j*a
5
另求建议应该注意些啥,免得被RFE。 硬条件应该不会有啥变化了

【在 j****a 的大作中提到】
: 各位同鞋给看看吧,多谢。条件如下:
: 1. Ph.D. in chemical engineering.
: 2. Working in a international pharmaceutical company as a scientist.
: 3. 6 published papers (with 5 1st author) mostly with pharmaceutical
: sciences journal, 1 more paper will be accepted before filing EB1B (1st
: author)
: 4. No award, no media report
: 5. Two patent applications, both as the last inventor (does it matter?)
: 6. Prepare to get 6 reference letters, (got three already, two independent
: from europe and one from US)

avatar
l*c
6
Sha fa!
avatar
n*w
7
strong enough
avatar
y*0
8
EB3进到2011年10月了。。。
avatar
c*o
9
同文专利作者的排序跟paper的一样重要么?
avatar
m*x
10
恭贺eb3c领先eb2c三十五个月
板凳坐等大厨来我们这儿开中餐馆
avatar
d*3
11
REVIEW很够, 文章数一般不过5个一作很不错应该很好突出authorship/contribution
, CITATION有点低不过去找找同方向的平均引用看看。
准备材料的时候一定要突出重点强调你最强的部分, 不足的没把握的就别提(在CV里
面也别提)

【在 j****a 的大作中提到】
: 另求建议应该注意些啥,免得被RFE。 硬条件应该不会有啥变化了
avatar
c*6
12
你没抢上

【在 l*******c 的大作中提到】
: Sha fa!
avatar
j*a
13
多谢comment

contribution

【在 d*****3 的大作中提到】
: REVIEW很够, 文章数一般不过5个一作很不错应该很好突出authorship/contribution
: , CITATION有点低不过去找找同方向的平均引用看看。
: 准备材料的时候一定要突出重点强调你最强的部分, 不足的没把握的就别提(在CV里
: 面也别提)

avatar
l*A
14
Wow.... Look at eb3.. Nice.
avatar
j*a
15
求more 评估和建议。 Thanks.
avatar
p*z
17
很牛
avatar
c*6
18
你说的太严重了。只是2010年下半年和2011的PD比EB2好一点
根据140data 加起来不过几百人 加上家属才1千多
As the rate of applicants who are able to have action on their cases
finalized increases, it could have a significant impact on the cut-off date
situation.
是说没有人交申请么?还是RFE 没有回复呀?

【在 m*****t 的大作中提到】
: EB3C有点逆天了。
avatar
j*a
19
多谢大家的comments. 我觉得我的条件其实挺弱的,尤其是publication 和citation.
希望听到些不同的声音。对我准备非常有帮助,再次谢过。

【在 j****a 的大作中提到】
: 各位同鞋给看看吧,多谢。条件如下:
: 1. Ph.D. in chemical engineering.
: 2. Working in a international pharmaceutical company as a scientist.
: 3. 6 published papers (with 5 1st author) mostly with pharmaceutical
: sciences journal, 1 more paper will be accepted before filing EB1B (1st
: author)
: 4. No award, no media report
: 5. Two patent applications, both as the last inventor (does it matter?)
: 6. Prepare to get 6 reference letters, (got three already, two independent
: from europe and one from US)

avatar
F*u
20
这段时间的EB2可是好几千人,都眼红得看着呢

date

【在 c*******6 的大作中提到】
: 你说的太严重了。只是2010年下半年和2011的PD比EB2好一点
: 根据140data 加起来不过几百人 加上家属才1千多
: As the rate of applicants who are able to have action on their cases
: finalized increases, it could have a significant impact on the cut-off date
: situation.
: 是说没有人交申请么?还是RFE 没有回复呀?

avatar
b*h
21
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。